U.S. Infrastructure Stock News

Over the last 7 days, the United States market has experienced a 2.5% decline, though it has seen a significant rise of 23% over the past year, with earnings projected to grow by 17% annually. In this context, identifying stocks that are estimated to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets in an evolving market landscape.

Over the last 7 days, the United States market has dropped 2.5%, yet it remains up by 23% over the past year, with earnings projected to grow by 17% annually in the coming years. In this fluctuating environment, identifying growth companies with high insider ownership can be particularly appealing as these firms often demonstrate strong potential and a vested interest from those who know them best.

Over the last 7 days, the United States market has dropped 2.5%, but it remains up 23% over the past year with earnings forecasted to grow by 17% annually. For investors looking beyond well-known stocks, penny stocks—often representing smaller or newer companies—can present intriguing opportunities despite their somewhat outdated label. By focusing on those with strong financial health and potential for growth, investors might uncover valuable options in this niche area of the market.

Some Dave Inc. ( NASDAQ:DAVE ) shareholders may be a little concerned to see that the Co-Founder, Jason Wilk, recently...

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this dynamic environment, identifying dividend stocks that offer consistent payouts and potential for growth can be an effective strategy for investors seeking to balance income with capital appreciation.

Investors who take an interest in Offerpad Solutions Inc. ( NYSE:OPAD ) should definitely note that the Founder, Brian...

Anyone interested in indie Semiconductor, Inc. ( NASDAQ:INDI ) should probably be aware that the Chief Operating...

We note that the Outset Medical, Inc. ( NASDAQ:OM ) CFO, Principal Financial Officer & Principal Accounting Officer...

We wouldn't blame GoDaddy Inc. ( NYSE:GDDY ) shareholders if they were a little worried about the fact that Amanpal...

Investors who take an interest in Corbus Pharmaceuticals Holdings, Inc. ( NASDAQ:CRBP ) should definitely note that the...

Some Maplebear Inc. ( NASDAQ:CART ) shareholders may be a little concerned to see that the Lead Independent Director...

Some Diamondback Energy, Inc. ( NASDAQ:FANG ) shareholders may be a little concerned to see that insider Lyndal Greth...

Potential SmartFinancial, Inc. ( NYSE:SMBK ) shareholders may wish to note that the Independent Director, Cathy...

Event overview and recent stock context Antero Midstream (AM) continues to draw interest after recent trading, with the stock last closing at US$21.52. The company’s market value stands at about US$10.22b, supported by all reported revenue coming from the United States. See our latest analysis for Antero Midstream. Recent trading shows modest short term softness, with a 1 day share price return of 0.28% and a 90 day share price return down 4.74%. The year to date share price return of 19.96%...

In early June 2026, Axos Financial benefited from renewed interest in regional banks as higher-for-longer interest rates supported expanding net interest margins and sector-wide optimism following Q1 earnings. This sector tailwind highlights how Axos Financial’s margin profile and perceived resilience are increasingly tied to broader trends in deposit costs and loan yields. Next, we’ll examine how this improving net interest margin backdrop interacts with Axos Financial’s existing investment...

Upwork Inc. recently refreshed its Board of Directors after the June 4, 2026 annual meeting, appointing Xero CFO Claire Bramley and former Bright Horizons CEO David Lissy to the Board and its Audit, Risk, and Compliance Committee, while Anilu Vazquez-Ubarri and Leela Srinivasan concluded their multi-year service. The addition of deeply experienced finance and scaling leaders signals Upwork’s intent to reinforce governance as it pursues its AI-enabled labor marketplace ambitions. We’ll now...

Recent performance snapshot and context Artisan Partners Asset Management (APAM) has drawn renewed attention as investors reassess the stock after recent trading, with shares closing at US$37.19 and returns mixed across different time frames. Over the past month, the stock is down 2.2%, while the past 3 months show a gain of 1.7%. Year to date, the share price is down 10.2%, and the 1 year total return is down 1.3%. See our latest analysis for Artisan Partners Asset Management. Recent trading...

In early June 2026, law firm Halper Sadeh LLC announced it is investigating whether certain Estée Lauder Companies officers and directors breached fiduciary duties to shareholders, potentially leading to legal or governance actions. This investigation brings Estée Lauder’s board oversight and corporate governance practices into sharper focus, raising questions about management accountability and future policy reforms. We’ll now examine how this governance-focused investigation could reshape...

We wouldn't blame SiTime Corporation ( NASDAQ:SITM ) shareholders if they were a little worried about the fact that...

Essent Group (ESNT) is back in focus after Keefe, Bruyette & Woods upgraded the stock to Outperform, following a Q1 2026 earnings report that exceeded market expectations on both revenue and earnings per share. See our latest analysis for Essent Group. At a share price of US$57.44, Essent Group has seen short term share price pressure, with the 30 day share price return down 9.01% and the year to date share price return down 11.18%. At the same time, the 1 year total shareholder return is...

BridgeBio Pharma (BBIO) is back in focus after the FDA accepted its New Drug Application for BBP-418 with Priority Review for limb-girdle muscular dystrophy type 2I/R9, setting a PDUFA action date of November 27, 2026. See our latest analysis for BridgeBio Pharma. The FDA action has arrived while the share price has moved around, with a 7 day share price return of 3.44%, a year to date share price return down 13.58%, and a 1 year total shareholder return of 73.23% alongside a very large 3...

ASP Isotopes Inc. recently reported that it has successfully restarted and optimized the first 18 stages of its Silicon-28 enrichment facility in Pretoria, South Africa, after installing upgrades to valves, compressors, and piping and confirming enrichment performance against theoretical calculations. The company now plans to extend these engineering enhancements across the remaining stages to support commercial-scale production of enriched Silicon-28, a material with emerging importance for...

Biogen (BIIB) is back in the spotlight after the FDA granted Breakthrough Therapy Designation to its spinal muscular atrophy candidate salanersen, alongside encouraging Phase 3 lupus data for dapirolizumab pegol presented with partner UCB. See our latest analysis for Biogen. The recent FDA Breakthrough Therapy Designation for salanersen and positive lupus data arrive as Biogen’s share price trades at US$195.34, with a 1-year total shareholder return of 45.61% contrasting with weaker 3 and 5...

Bank of America (BAC) is back in focus after outlining plans for a cross-border real-time payments service launching next quarter, a move that highlights its push in global transaction banking. See our latest analysis for Bank of America. Recent announcements around cross-border real-time payments, tokenized deposits and regional leadership changes come against a backdrop of firm momentum. The 90 day share price return is 10.85% and the 1 year total shareholder return is 22.58%, while the...